86 results
Page 4 of 5
F-1/A
v0fu1ec
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
toyud5avthcdzvhh314
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
5xn3p0diinirja55
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
EX-1.1
bppxrclv0uyy5
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
6vcvdo6vzmnbv4kej71
26 Mar 20
Registration statement (foreign) (amended)
12:00am
6-K
EX-99.2
j8xpgv
24 Mar 20
Therapix Biosciences Ltd. Signs Securities Purchase Agreement
12:00am
F-1/A
EX-4.7
hjsfr6ma1v1f5g3x4tzl
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1/A
52ul r9extg36dcsae
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
z8vjbttrxt
31 Jan 20
Registration statement (foreign)
12:00am
424B5
4oc7ne
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
wqxc 1419dj
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
F-3/A
hv9a2g
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
F-3/A
EX-4.2
2yptctl48c
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
D
m8hpn
9 Apr 19
$2.25M in options, sold $2.25M, 8 investors
9:04am
424B5
tg6qm0 2sw
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-10.1
oclgwrfeh3
28 Mar 19
Therapix Biosciences Announces Pricing
8:51am
6-K
EX-10.1
sq821
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am